...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >The Effect of Channa striatus (Haruan) Extract on Pain and Wound Healing of Post-Lower Segment Caesarean Section Women
【24h】

The Effect of Channa striatus (Haruan) Extract on Pain and Wound Healing of Post-Lower Segment Caesarean Section Women

机译:通道纹状体(HALUUN)提取物对低层分部剖腹产剖面女性疼痛和伤口愈合的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Channa striatus has been consumed for decades as a remedy to promote wound healing by women during postpartum period. The objectives of this study were to compare postoperative pain, wound healing based on wound evaluation scale (WES), wound cosmetic appearance based on visual analogue scale (VAS) scores and patient satisfaction score (PSS), and safety profiles between C. striatus group and placebo group after six weeks of lower segment caesarean section (LSCS) delivery. A randomised, double-blind, placebo-controlled study was conducted. Subjects were randomised in a ratio of 1:1 into either the C. striatus group (500 mg daily) or placebo group (500 mg of maltodextrin daily). 76 subjects were successfully randomised, with 38 in the C. striatus group and 35 in the placebo group. There were no significant differences in postoperative pain (p = 0.814) and WES (p = 0.160) between the C. striatus and placebo groups. However, VAS and PSS in the C. striatus group were significantly better compared with the placebo group (p = 0.014 and p < 0.001, resp.). The safety profiles showed no significant differences between the groups. In conclusion, six-week supplementation of 500 mg of C. striatus extract showed marked differences in wound cosmetic appearance and patient's satisfaction and is safe for human consumption.
机译:Channa Striatus已被消耗为几十年作为产后期间促进妇女伤口治疗的补救措施。本研究的目标是基于伤口评估秤(WES),基于视觉模拟量表(VAS)评分和患者满意度(PSS)的伤口化妆品外观,以及C. Striatus集团之间的安全性剖面,比较术后疼痛,伤口化妆品外观和安慰剂组在六周的下部剖宫产段(LSC)交付后。进行随机,双盲,安慰剂对照研究。受试者以1:1的比例随机化,进入C. Striatus组(每日500mg)或安慰剂组(每日500毫克麦芽糖蛋白)。 76个受试者已成功随机化,C.Striatus组38中,安慰剂组35。术后疼痛(P = 0.814)和C.Striatus和安慰剂组之间的WES(P = 0.160)没有显着差异。然而,与安慰剂组相比,C. Striatus组中的VAS和PSS显着更好(P = 0.014和P <0.001,RES)。安全型材在组之间没有显着差异。总之,六周补充500毫克C. Striatus提取物在伤口化妆品外观和患者的满意度方面表现出显着的差异,对人类消费安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号